Search results for: 'pipeline assessment for cardiovascular disease'

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...

Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitoch...

Insurtech risk assessment and analytics has grown because of the digitization of the insurance industry and the demand for online insurance products and secure data management. Companies in this segment leverage artificial intelligence (AI), machine learning (ML), and big data analytics to provide insurers with more accurate and actionable risk...

This study highlights emerging companies in the cardiovascular space. Cardiovascular disease detection and monitoring have been gaining significant attention considering rising healthcare costs and challenges related to the availability of a skilled healthcare workforce. Companies are trying to address these challenges with technology-driven so...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

The global economy in recent years has faced a multitude of challenges such as the 2018 US-China Trade war, the 2020 COVID-19 pandemic, the 2022 Russo-Ukrainian war, as well as the recent 2023 Israel-Hamas war. These geopolitical upheavals have significantly impacted the socio-economic stability of countries across the world, with developed and eme...